India Gene Therapy Market Research Report 2022: Prospects, Trends, Market Size and Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “India Gene Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2028” report has been added to ResearchAndMarkets.com’s offering. The country research report on India gene therapy market is a customer intelligence and competitive study of the India market. Moreover, the report provides deep insights into demand forecasts, market trends, and, … [Read more…]

The Worldwide Glaucoma Treatment Industry is Expected to Reach $9.1 Billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Glaucoma Treatment Market (2022-2027) by Type, Indication, Sales Channel, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Glaucoma Treatment Market is estimated to be USD 5.94 Bn in 2022 and is expected to reach USD 9.1 Bn by 2027, growing … [Read more…]

European Union CBD Cosmetics Regulation Report 2022: Updates On EU and Member State Positions – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “EU CBD Cosmetics Regulation: Updates On EU and Member State Positions” report has been added to ResearchAndMarkets.com’s offering. This report seeks to outline the substance of the discussion at the EU level about the use of CBD and other hemp ingredients in cosmetic products, gleaned from documents CBD-Intel has obtained from EU authorities … [Read more…]

United States Study of Arthritis Pain Relief 2021-2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The 2021 US Study of Arthritis Pain Relief” report has been added to ResearchAndMarkets.com’s offering. The 2021 U.S. Study of Arthritis Pain Relief, the second in a series, is a nationally representative study exploring arthritis sufferer awareness, experience with and attitudes toward Rx and OTC oral and topical pain relievers as well as … [Read more…]

Global HER2-Negative Breast Cancer Drug Pipeline Research Report 2022: Comprehensive Insights About 85+ Companies and 85+ Pipeline Drugs – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global HER2-Negative Breast Cancer – Pipeline Insight, 2022” drug pipelines has been added to ResearchAndMarkets.com’s offering. This “HER2-Negative Breast Cancer – Pipeline Insight, 2022” report provides comprehensive insights about 85+ companies and 85+ pipeline drugs in HER2-Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. … [Read more…]

Hillsdale College Academy for Science and Freedom Releases Statement on “Ethical Principles of Public Health”

The 10-point statement was coauthored by 12 prominent medical science, public health, and biomedical ethics experts from around the world HILLSDALE, Mich.–(BUSINESS WIRE)–The Academy for Science and Freedom at Hillsdale College has released a statement entitled “Ethical Principles of Public Health.” The statement, coauthored by a dozen prominent medical science, public health, and biomedical ethics … [Read more…]

The Worldwide Spinal Cord Neurostimulation Implant Industry is Expected to Reach $7.3 Billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Spinal Cord Neurostimulation Implant Market Research Report by Spinal Cord Stimulator, Lead Type, Application, End User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Spinal Cord Neurostimulation Implant Market size was estimated at USD 3,127.32 million in 2021, USD 3,598.60 million … [Read more…]

Incyte Announces FDA Approval of Pemazyre® (pemigatinib) as the First and Only Targeted Treatment for Myeloid/Lymphoid Neoplasms (MLNs) with FGFR1 Rearrangement

– This marks the second indication for Pemazyre, which received accelerated FDA approval in 2020 for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement – Pemazyre is the only FGFR inhibitor with multiple indications WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that … [Read more…]

 Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine

Submission follows application for Omicron BA.1-adapted bivalent vaccine submitted in July If authorized, both Omicron BA.1-adapted and Omicron BA.4/BA.5-adapted bivalent vaccines will be available in the European Union as early as September NEW YORK & MAINZ, Germany–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the … [Read more…]

Global Women’s Digital Health Market Research Report to 2027 – Featuring Agile Therapeutics, Amgen and Bayer Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Women’s Digital Health Market Research Report by Type (Diagnostic Tools, Mobile Apps, and Wearable Devices), Distribution Channel, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Women’s Digital Health Market size was estimated … [Read more…]